DMK: DMK Pharmaceuticals Commences Restructuring Proceeding

(marketscreener.com) DMK Pharmaceuticals Corporation , a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, and certain of its direct and indirect subsidiaries today commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S....https://www.marketscreener.com/quote/stock/DMK-PHARMACEUTICALS-CORPO-15227729/news/DMK-Pharmaceuticals-Commences-Restructuring-Proceeding-45878052/?utm_medium=RSS&utm_content=20240202